AU2001229682A1 - Small cell lung cancer associated antigens and uses therefor - Google Patents

Small cell lung cancer associated antigens and uses therefor

Info

Publication number
AU2001229682A1
AU2001229682A1 AU2001229682A AU2968201A AU2001229682A1 AU 2001229682 A1 AU2001229682 A1 AU 2001229682A1 AU 2001229682 A AU2001229682 A AU 2001229682A AU 2968201 A AU2968201 A AU 2968201A AU 2001229682 A1 AU2001229682 A1 AU 2001229682A1
Authority
AU
Australia
Prior art keywords
lung cancer
small cell
cell lung
associated antigens
cancer associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229682A
Inventor
Yao-Tseng Chen
Ali O. Gure
Dirk Jager
Lloyd J. Old
Matthew J Scanlan
Elisabeth Stockert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Cornell Research Foundation Inc
Memorial Sloan Kettering Cancer Center
Original Assignee
Ludwig Institute for Cancer Research Ltd
Sloan Kettering Institute for Cancer Research
Cornell Research Foundation Inc
Ludwig Institute for Cancer Research New York
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Sloan Kettering Institute for Cancer Research, Cornell Research Foundation Inc, Ludwig Institute for Cancer Research New York, Memorial Sloan Kettering Cancer Center filed Critical Ludwig Institute for Cancer Research Ltd
Publication of AU2001229682A1 publication Critical patent/AU2001229682A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001229682A 2000-01-21 2001-01-19 Small cell lung cancer associated antigens and uses therefor Abandoned AU2001229682A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48910100A 2000-01-21 2000-01-21
US09489101 2000-01-21
PCT/US2001/002015 WO2001053349A2 (en) 2000-01-21 2001-01-19 Small cell lung cancer associated antigens and uses therefor

Publications (1)

Publication Number Publication Date
AU2001229682A1 true AU2001229682A1 (en) 2001-07-31

Family

ID=23942405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229682A Abandoned AU2001229682A1 (en) 2000-01-21 2001-01-19 Small cell lung cancer associated antigens and uses therefor

Country Status (4)

Country Link
US (1) US7314721B2 (en)
EP (1) EP1259545A2 (en)
AU (1) AU2001229682A1 (en)
WO (1) WO2001053349A2 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476518A1 (en) * 2002-02-22 2003-09-04 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20050221339A1 (en) * 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
EP1907581A2 (en) * 2005-07-27 2008-04-09 Oncotherapy Science, Inc. Method of diagnosing small cell lung cancer
JP2009516178A (en) * 2005-11-10 2009-04-16 ユニバーシティー オブ ケンタッキー Lung cancer diagnostic assay
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
WO2007081387A1 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices, methods of use, and kits for performing diagnostics
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
WO2007133710A2 (en) 2006-05-11 2007-11-22 Raindance Technologies, Inc. Microfluidic devices and methods of use thereof
JP2010507069A (en) * 2006-07-08 2010-03-04 ユニバーシティー オブ ケンタッキー リサーチ ファンデーション Lung cancer diagnostic assay
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) * 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
KR20110134482A (en) * 2009-03-19 2011-12-14 도꾸리쯔교세이호징 가가꾸 기쥬쯔 신꼬 기꼬 Hla-a24-binding cancer antigen peptide derived from sox2
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
EP2486409A1 (en) 2009-10-09 2012-08-15 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
WO2011059920A2 (en) 2009-11-10 2011-05-19 The J. David Gladstone Institutes Methods of generating neural stem cells
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
CA2789425C (en) 2010-02-12 2020-04-28 Raindance Technologies, Inc. Digital analyte analysis with polymerase error correction
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
JP5808349B2 (en) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー Biomarkers for theranosis
KR20130043104A (en) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 Circulating biomarkers for disease
EP2622103B2 (en) 2010-09-30 2022-11-16 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
EP2673614B1 (en) 2011-02-11 2018-08-01 Raindance Technologies, Inc. Method for forming mixed droplets
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3216872B1 (en) 2011-06-02 2020-04-01 Bio-Rad Laboratories, Inc. Enzyme quantification
AU2012267884A1 (en) * 2011-06-07 2014-01-23 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for cancer
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP2844768B1 (en) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digital analyte analysis
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
EP3090063B1 (en) 2013-12-31 2019-11-06 Bio-Rad Laboratories, Inc. Method for detection of latent retrovirus
GB201507030D0 (en) 2015-04-24 2015-06-10 Immatics Biotechnologies Gmbh Immunotherapy against lung cancers, in particular NSCLC
US20180148486A1 (en) * 2015-05-29 2018-05-31 Clark Atlanta University Human cell lines mutant for zic2
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
EP3392656A1 (en) 2017-04-20 2018-10-24 Euroimmun Medizinische Labordiagnostika AG Diagnosis of a neuroautoimmune disease
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CA3194508A1 (en) 2020-09-15 2022-03-24 Universite Claude Bernard Lyon 1 Anti-argonaute protein autoantibodies as biomarkers of autoimmune neurological diseases
US20220308053A1 (en) 2021-03-29 2022-09-29 Euroimmun Medizinische Labordiagnostika Ag Method and reagents for the detection of an autoantibody
DE202022104518U1 (en) 2021-08-10 2023-06-20 Fundació Clínic Per A La Recerca Biomèdica (Fcrb) Autoantibodies and means for detecting an autoantibody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610013A (en) * 1993-07-22 1997-03-11 Ludwig Institute For Cancer Research Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
US5698396A (en) * 1995-06-07 1997-12-16 Ludwig Institute For Cancer Research Method for identifying auto-immunoreactive substances from a subject
US6297364B1 (en) * 1998-04-17 2001-10-02 Ludwig Institute For Cancer Research Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
WO1999057438A1 (en) 1998-05-04 1999-11-11 Arisoy Yuecel The volume adjustable rotary systems
EP1082459A4 (en) * 1998-05-21 2002-09-25 Diadexus Inc A novel method of diagnosing, monitoring, and staging lung cancer

Also Published As

Publication number Publication date
US7314721B2 (en) 2008-01-01
WO2001053349A2 (en) 2001-07-26
WO2001053349A3 (en) 2002-01-10
EP1259545A2 (en) 2002-11-27
US20040126808A1 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
AU2001229682A1 (en) Small cell lung cancer associated antigens and uses therefor
AU2002225681A1 (en) Yeast-dentritic cell vaccines and uses thereof
AU2002251913A1 (en) Hybrid antibodies and uses thereof
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2002223028A1 (en) Inhaler
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002211717A1 (en) Stresscopins and their uses
AU2002349543A1 (en) Tumor antigens
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001229770A1 (en) Improved research and development process
AU2002214083A1 (en) Secure keyboard
AU2001229439A1 (en) Bioconjugates and uses thereof
AUPR126500A0 (en) Documents envelope
AU2002243314A1 (en) Immunogenic cancer peptides and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
AU2001295582A1 (en) Tumour-related antigens
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU2002223344A1 (en) Sputum fixative and methods and uses therefor
AU5632500A (en) Cancer associated antigens and uses therefor
AU2001261534A1 (en) The meca-79 antigen and related methods
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU2002256556A1 (en) Sea-trosy and related methods
AU2001292330A1 (en) Drying-resistant yeast